LB-100, a novel Protein Phosphatase 2A (PP2A) Inhibitor, Sensitizes Malignant Meningioma Cells to the Therapeutic Effects of Radiation

Atypical and anaplastic meningiomas (AAM) represent 20% of all meningiomas. They are associated with poor outcomes due to their tendency to recur. While surgery and radiation (RT) are first line therapy, no effective systemic medical treatment has been identified. Protein phosphatase 2A (PP2A) is a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Lett
Main Authors: Ho, Winson SC., Sizdahkhani, Saman, Hao, Shuyu, Song, Hua, Seldomridge, Ashlee, Tandle, Anita, Maric, Dragan, Kramp, Tamalee, Lu, Rongze, Heiss, John D., Camphausen, Kevin, Gilbert, Mark R., Zhuang, Zhengping, Park, Deric M.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748254/
https://ncbi.nlm.nih.gov/pubmed/29199006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.11.035
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki